Canada vs OECD members: Treatment for hypertension, male
Canada
75.8%
in 2019
OECD members
54.5%
in 2019
Canada rank
1st
OECD members rank
3rd
Treatment for hypertension, male over time
- Canada
- OECD members
How they compare
Canada currently reports 75.8% against 54.5% in OECD members, a difference of 21.3%.
That makes Canada's figure about 1.4 times OECD members's.
Across all 30 years both countries report, Canada has been ahead every year.
Canada ranks 1st and OECD members ranks 3rd of 192 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | OECD members | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 39.2% | 31.8% | 7.4% | Canada |
| 2000s | 61.1% | 43.1% | 18.0% | Canada |
| 2010s | 73.6% | 52.2% | 21.4% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, male, Canada or OECD members?
- Canada, at 75.8% against 54.5% in OECD members as of 2019.
- What is the difference in treatment for hypertension, male between Canada and OECD members?
- 21.3%, with Canada ahead.
- How many years of comparable data are there for Canada and OECD members?
- 30 years are reported by both, from 1990 to 2019.
- How do Canada and OECD members rank globally for treatment for hypertension, male?
- Canada ranks 1st and OECD members ranks 3rd of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.